These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 9931008)

  • 1. Time-resolved monitoring of electrogenic Na+-Ca2+ exchange in the isolated cardiac sarcolemma vesicles by using a rapid-response fluorescent probe.
    Baazov D; Wang X; Khananshvili D
    Biochemistry; 1999 Feb; 38(5):1435-45. PubMed ID: 9931008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid interaction of FRCRCFa with the cytosolic side of the cardiac sarcolemma Na(+)-Ca2+ exchanger blocks the ion transport without preventing the binding of either sodium or calcium.
    Khananshvili D; Baazov D; Weil-Maslansky E; Shaulov G; Mester B
    Biochemistry; 1996 Dec; 35(49):15933-40. PubMed ID: 8961960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positively charged cyclic hexapeptides, novel blockers for the cardiac sarcolemma Na(+)-Ca2+ exchanger.
    Khananshvili D; Shaulov G; Weil-Maslansky E; Baazov D
    J Biol Chem; 1995 Jul; 270(27):16182-8. PubMed ID: 7608184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiac Na(+)-Ca2+ exchanger: relative rates of calcium and sodium movements and their modulation by protonation-deprotonation of the carrier.
    Khananshvili D; Weil-Maslansky E
    Biochemistry; 1994 Jan; 33(1):312-9. PubMed ID: 8286352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low molecular weight inhibitor of NCX1 interacts with a cytosolic domain that differs from the ion-transport site of the Na/Ca exchanger.
    Shpak C; Hiller R; Shpak B; Boyman L; Khananshvili D
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1346-51. PubMed ID: 15504362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of myristyl-FRCRCFa, a cell-permeant blocker of the cardiac sarcolemmal Na-Ca exchanger, tested in rabbit ventricular myocytes.
    Convery MK; Levi AJ; Khananshvili D; Hancox JC
    Pflugers Arch; 1998 Jul; 436(4):581-90. PubMed ID: 9683732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phe-Met-Arg-Phe-NH2 (FMRFa)-related peptides inhibit Na(+)-Ca2+ exchange in cardiac sarcolemma vesicles.
    Khananshvili D; Price DC; Greenberg MJ; Sarne Y
    J Biol Chem; 1993 Jan; 268(1):200-5. PubMed ID: 8416928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and activation of Na+-Ca2+ exchange activity by quinacrine.
    de la Peña P; Reeves JP
    Am J Physiol; 1987 Jan; 252(1 Pt 1):C24-9. PubMed ID: 3101507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unknown endogenous inhibitor of Na/Ca exchange can enhance the cardiac muscle contractility.
    Hiller R; Shpak C; Shavit G; Shpak B; Khananshvili D
    Biochem Biophys Res Commun; 2000 Oct; 277(1):138-46. PubMed ID: 11027654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Na+-Ca2+ exchange in sarcolemmal vesicles by intravesicular Ca2+.
    Reeves JP; Poronnik P
    Am J Physiol; 1987 Jan; 252(1 Pt 1):C17-23. PubMed ID: 3101506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical block of the Na+-Ca2+ exchanger by extracellular protons in guinea-pig ventricular myocytes.
    Egger M; Niggli E
    J Physiol; 2000 Mar; 523 Pt 2(Pt 2):353-66. PubMed ID: 10699080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate-limiting mechanisms of exchange reactions in the cardiac sarcolemma Na(+)-Ca2+ exchanger.
    Khananshvili D; Shaulov G; Weil-Maslansky E
    Biochemistry; 1995 Aug; 34(32):10290-7. PubMed ID: 7640285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of endotoxin-induced impairment in Na+-Ca2+ exchange in canine myocardium.
    Liu MS; Xuan YT
    Am J Physiol; 1986 Dec; 251(6 Pt 2):R1078-85. PubMed ID: 2947479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid composition modulates the Na+-Ca2+ exchange activity of cardiac sarcolemma in reconstituted vesicles.
    Vemuri R; Philipson KD
    Biochim Biophys Acta; 1988 Jan; 937(2):258-68. PubMed ID: 3276350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electrogenic Na+/Ca2+ antiporter in addition to the Ca2+ pump in cardiac sarcolemma.
    Lamers JM; Stinis JT
    Biochim Biophys Acta; 1981 Jan; 640(2):521-34. PubMed ID: 7213903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of two distinct Mg(2+) extrusion mechanisms in cardiac sarcolemmal vesicles.
    Cefaratti C; Romani AM
    Mol Cell Biochem; 2007 Sep; 303(1-2):63-72. PubMed ID: 17415622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na(+)-Ca2+ exchangers from rod outer segments and cardiac sarcolemma: comparison of properties.
    Nicoll DA; Barrios BR; Philipson KD
    Am J Physiol; 1991 Jun; 260(6 Pt 1):C1212-6. PubMed ID: 1905482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-dependent modulation of ion binding and translocation in the cardiac Na(+)-Ca2+ exchange system.
    Khananshvili D
    J Biol Chem; 1991 Jul; 266(21):13764-9. PubMed ID: 1906884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 1. Mechanism of inhibition by amiloride analogues.
    Slaughter RS; Garcia ML; Cragoe EJ; Reeves JP; Kaczorowski GJ
    Biochemistry; 1988 Apr; 27(7):2403-9. PubMed ID: 3382630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal Ca2+i stimulation of cardiac Na+/Ca2+ exchange requires simultaneous alkalinization and binding of PtdIns-4,5-P2 to the exchanger.
    Posada V; Beaugé L; Berberián G
    Biol Chem; 2007 Mar; 388(3):281-8. PubMed ID: 17338635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.